Date of publication:
Reading time:
Author:
We are proud to announce that our Penta Hospitals centre at ul. Pilczycka, together with Dr. Anna Domagała as Principal Researcher, was the first in Poland and the second in Europe to enrol a patient in a clinical trial on hidradenitis suppurativa (acne inversa).
This achievement is not only a source of satisfaction but also confirmation of our operational readiness, high recruitment efficiency, and continuous collaboration with patients and research teams.
For sponsors and partners, this means that:
It is a chronic inflammatory skin disease characterized by painful nodules, abscesses, and fistulas, most commonly occurring in the underarm, groin, and inframammary areas. The condition significantly reduces quality of life and may lead to serious complications and scarring.
If you suspect hidradenitis suppurativa in yourself or someone close to you, learn more about this clinical trial.
Why participate in our clinical trial programs?
Penta Hospitals Poland is not just modern infrastructure it is a vision of the future of clinical research, already being implemented today based on experience, quality, and a patient-centred approach.
Share article:
